Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	2.01	81.49	79.89
Graham Fair Price	244.74	722.46	209.56
PEG	-98.41	0.03	-2.09
Price/Book	7.30	1.84	1.72
Price/Cash Flow	38.05	-47.42	-76.55
Prices/Earnings	-89.44	33.23	314.59
Price/Sales	46.04	3.62	2.48
Price/FCF	38.05	-47.42	-76.55
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	81.85	0.16	0.09
Operating Margin	55.91	0.04	0.02
ROA	946.67	< 0.005	< 0.005
ROE	< 0.005	0.01	915.87
ROIC	< 0.005	< 0.005	30.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	-0.09	-11.16
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.28	0.24	-89.50
EPS QOQ	1.51	10.01	564.32
FCF QOQ	-1.70	-0.87	48.54
Revenue QOQ	0.30	-0.21	-32.32
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.55	31.28	78.21
Days Sales Outstanding (DSO)	87.44	106.81	22.15
Inventory Turnover	5.13	2.88	-43.89
Debt/Capitalization	0.44	0.44	-0.06
Quick Ratio	0.81	0.79	-3.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1195.21	1292.76	8.16
Cash	187.45	215.81	15.13
Capex	-17.90	-28.05	-56.68
Free Cash Flow	-26.85	-50.30	-87.35
Revenue	828.93	658.75	-20.53
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.04	1.04	0.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.56	21.87	-3.06
Naive Interpretation	Member

06 - Financial Health · Bad

Rating